Resultats de la cerca - Gregory D. Busse

  • Mostrar 1 - 3 resultats de 3
Refinar resultats
  1. 1
    A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

    A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hypera... per Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Fatima Chowdhry, Gregory D. Busse, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder

    A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder per Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Gregory D. Busse, Fatima Chowdhry, Andrew J. Cutler, Nandita Joshi Jones, Robert L. Findling, Stefan Schwabe

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial

    Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial per Jenny Downs, Peter Jacoby, Nicola Specchio, H Cross, S Amin, Nadia Bahi‐Buisson, Rajsekar R. Rajaraman, Bernhard Suter, Orrin Devinsky, A Aimetti, Gregory D. Busse, Heather E. Olson, S Demarest, T A Benke, E Pestana-Knight

    Publicat 2024
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: